BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22565645)

  • 1. SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status.
    López-Corral L; Sarasquete ME; Beà S; García-Sanz R; Mateos MV; Corchete LA; Sayagués JM; García EM; Bladé J; Oriol A; Hernández-García MT; Giraldo P; Hernández J; González M; Hernández-Rivas JM; San Miguel JF; Gutiérrez NC
    Leukemia; 2012 Dec; 26(12):2521-9. PubMed ID: 22565645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization.
    Lo KC; Bailey D; Burkhardt T; Gardina P; Turpaz Y; Cowell JK
    Genes Chromosomes Cancer; 2008 Mar; 47(3):221-37. PubMed ID: 18050302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H; Facon T; Daviet A; Godon C; Rapp MJ; Harousseau JL; Grosbois B; Bataille R
    Cancer Res; 1999 Sep; 59(18):4546-50. PubMed ID: 10493504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.
    Mikulasova A; Smetana J; Wayhelova M; Janyskova H; Sandecka V; Kufova Z; Almasi M; Jarkovsky J; Gregora E; Kessler P; Wrobel M; Walker BA; Wardell CP; Morgan GJ; Hajek R; Kuglik P
    Eur J Haematol; 2016 Dec; 97(6):568-575. PubMed ID: 27157252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
    Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analyzing the profile of chromosomal imbalances in esophageal atypical hyperplasia and early stage esophageal squamous cell carcinoma by 250K Snp Array].
    Zhang X; Zhu ZH; Lin P; Yang H; Fu JH; Zhang LJ; Long H; Wen J; Huang XP; Fang Y; Rong TH
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2636-41. PubMed ID: 19080713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma.
    Kurashina K; Yamashita Y; Ueno T; Koinuma K; Ohashi J; Horie H; Miyakura Y; Hamada T; Haruta H; Hatanaka H; Soda M; Choi YL; Takada S; Yasuda Y; Nagai H; Mano H
    Cancer Sci; 2008 Sep; 99(9):1835-40. PubMed ID: 18564138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
    Agnelli L; Mosca L; Fabris S; Lionetti M; Andronache A; Kwee I; Todoerti K; Verdelli D; Battaglia C; Bertoni F; Deliliers GL; Neri A
    Genes Chromosomes Cancer; 2009 Jul; 48(7):603-14. PubMed ID: 19396863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma.
    Walker BA; Leone PE; Jenner MW; Li C; Gonzalez D; Johnson DC; Ross FM; Davies FE; Morgan GJ
    Blood; 2006 Sep; 108(5):1733-43. PubMed ID: 16705090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.
    Walker BA; Leone PE; Chiecchio L; Dickens NJ; Jenner MW; Boyd KD; Johnson DC; Gonzalez D; Dagrada GP; Protheroe RK; Konn ZJ; Stockley DM; Gregory WM; Davies FE; Ross FM; Morgan GJ
    Blood; 2010 Oct; 116(15):e56-65. PubMed ID: 20616218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
    Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA
    Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
    Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
    Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis.
    Ross CW; Ouillette PD; Saddler CM; Shedden KA; Malek SN
    Clin Cancer Res; 2007 Aug; 13(16):4777-85. PubMed ID: 17699855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent gains of the short arm of chromosome 9 in multiple myeloma with normal G-banded karyotype detected by comparative genomic hybridization.
    Tchinda J; Volpert S; Kropff M; Berdel WE; Kienast J; Meinhardt F; Horst J
    Am J Clin Pathol; 2004 Dec; 122(6):875-82. PubMed ID: 15539380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.